F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to accurately label insulin with resident's name
and date of opening for 6 (R3, R7, R11, R14, R16, R37) of 12 residents reviewed for medication labeling
and storage in a sample of 26.
Findings include:
On [DATE] at 10:10AM, the medication cart serving rooms 100 through 308 was observed to have 1
Novolog Flexpen with no name or open date, 2 of R14's Humalog Kwikpens with no open date, 1 Levemir
Flextouch with no name or open date, 1 Humalog Kwikpen with no name or open date, 1 of R11's Basaglar
pens with no date, 1 Lantus vial with no name or date, and 1 of R14's Lantus vials with no open date. V4
(Registered Nurse/RN) said all the insulins should be labeled with the resident's name and date of opening.
R7's face sheet documented an admission date of [DATE] and diagnoses including: hypertension, heart
failure, major depressive disorder. R7's Physician Order Sheet (POS) documented an [DATE] order for
Lantus 100 unit/ ml (milliliter) 25 units every morning.
R11's face sheet documented an admission date of [DATE] and diagnoses including: hypertension, anxiety
disorder, cerebral infarction, fatty liver. R11's POS documented a [DATE] order for Basaglar 100 unit/ ml 35
units at bedtime, an [DATE] order for Novolog 100 unit/ ml 8 units 3 times a day before meals, and a [DATE]
order for Novolog 100 unit/ ml sliding scale three times a day.
R14's face sheet documented an admission date of [DATE] and diagnoses including: anxiety disorder, type
2 diabetes mellitus, hypertension. R14's POS documented a [DATE] order for Lantus 100 unit/ ml 12 units
twice a day, [DATE] order for Humalog 100 unit/ ml sliding scale twice a day.
R37's face sheet documented an admission date of [DATE] and diagnoses including: anemia in chronic
kidney disease, end stage renal failure, type 2 diabetes mellitus, hypertension. R37's POS documented a
[DATE] order for Humalog 100 unit/ ml 3 units with meals three times daily, and a [DATE] order for Humalog
100 unit/ ml sliding scale twice a day.
On [DATE] at 1:38PM, V2 (Director of Nursing/DON) said R7, R11, R14, and R37 were the only residents
served from the 100 through 308 medication cart with orders for the types of undated insulins found.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
145890
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145890
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/06/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Eldorado Rehab & Healthcare
1001 A Jefferson Street
Eldorado, IL 62930
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
On [DATE] at 9:56AM, the medication cart serving rooms 400 through 504 was observed to have 2
Basaglar pens with no name or open date, 2 Novolog Flexpens with no name or open date, 2 Levemir
Flextouch with no name or open date, 1 Humalog Kwikpen with R16's name written on it but no opened
date. V5 (Licensed Practical Nurse/LPN) said he was unsure who the different insulins belonged to
because he mostly worked dayshift and those different type of insulins were given on a different shift. V5
said the resident's name and date of opening should be written on them.
R3's face sheet documented an admission date of [DATE] and diagnoses including: chronic diastolic heart
failure, type 2 diabetes mellitus, anemia in chronic kidney disease. R3's POS documented a [DATE] order
for Levemir 100 unit/ ml 20 units every morning, and a [DATE] order for Levemir 100 units/ ml 10 units every
night.
R16's face sheet documented an admission date of [DATE] and diagnoses including: heart failure, anxiety
disorder, major depressive disorder, obstructive sleep apnea. R16's POS documented a [DATE] order for
Basaglar 100 unit/ ml 40 units twice a day, a [DATE] Humalog 100 unit/ ml sliding scale twice a day.
On [DATE] at 1:38PM, V2 (DON) said R3 and R16 were the only residents served from the 400 through 504
medication cart with orders for the types of undated insulins found. V2 said all insulin pens and vials should
have the resident's name and date of opening on them. V2 said once insulin pens and vials are opened,
they have an expiration date depending on the type of insulin some being 28 days and some being 31 days.
V2 said if there was no open date on the insulin, staff would not know when the insulin becomes expired.
V2 said all insulins in the medication cart belong to specific residents and no multidose insulin pens or vials
were stock medications used for multiple residents.
The facility's [DATE] Insulin Administration policy documented in part .5. The nursing staff will have access
to specific instructions . on all forms of insulin delivery system(s) prior to their use 8. Facility will follow the
manufacturer guidelines for stability of insulins and pens. For storage and use . the vial or pen should be
dated when it is opened .Stability of Common Insulins in Vials and Pens . Opened at Room or Refrigerator
Temperature (days): Novolog FlexPen 28 days, Levmir FlexPen 42 days, Basaglar 28 days, Humalog 28
days, Lantus 28 days .
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145890
If continuation sheet
Page 2 of 2